We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastics. a New Risk Factor for Atherosclerotic Cardiovascular Disease
Summary
This paper reviews emerging evidence linking microplastic exposure to atherosclerotic cardiovascular disease, noting that MPs have been detected in arterial plaques and human tissues and may contribute to cardiovascular risk through inflammation, oxidative stress, and endothelial disruption.
ASCVD/CVD Risk Factors Plastics are a part of our day-to-day lives. Once plastic disintegrates, it generates microplastics, which are invisible to the human eye. So far, there is evidence that microplastics have been found in tissues of plants, animals, and human beings, but their role in the causality of diseases is not yet uncovered. Atherosclerosis results from inflammation and fat deposition in the arteries that lead to plaque formation. This research aims to determine whether atherosclerosis could be brought about by or worsened by microplastics. Extensive search was performed across multiple databases, including PubMed, Scopus, Medline, and Embase. Keywords like 'MICROPLASTICS", "MICROPLASTICS AND ATHEROSCLEROSIS", "ATHEROSCLEROSIS", "NANOPLASTICS", "NANOPLASTICS AND ATHEROSCLEROSIS", "MICROPLASTICS AND INFLAMMATION", "MICROPLASTICS AND ENDOTHELIAL DYSFUNCTION”, etc. were used to search. Articles were chosen based on their relevancy and recency. After an extensive search, 58 articles passed the criteria and were chosen to be a part of the study. 1. Microplastics are ubiquitous, and they enter the body by three major routes - inhalation, ingestion and direct skin contact. 2. Microplastics affect the pathogenesis of atherosclerosis: a. They induce lipid accumulation in the cytoplasm, predisposing to foam cell formation. Microplastics and nanoplastics up-regulate the scavenger receptor - MARCO- causing LDL accumulation and worsening inflammation. b. Microplastics up-regulate ICAM-1, VCAM -1, TNF-α expression, causing enhanced adherence, transendothelial migration of inflammatory cells, and inflammation. c. Microplastics cause phenotype switching of vascular smooth muscle cells, which is a key pathological event in the formation of an atheroma. d. Microplastics accumulate in the formed atheroma plaque and harbour a worse fate as compared to plaques without microplastics. Microplastics enter the body via three major routes- food, air, or by skin contact. In the cardiovascular system, they are known to cause free radical damage and cardiac fibrosis. Specific to atherogenesis, they affect every step. They predispose to dyslipidemia, they cause endothelial dysfunction and inflammation, and they additionally create a procoagulant environment. microplastics cause vascular smooth muscle cells phenotype switching and are shown to accumulate in the plaque and accelerate its growth. With the given information, one can infer that microplastic exposure has a detrimental effect on cardiovascular health.
Sign in to start a discussion.
More Papers Like This
Micro and Nano-plastic particles: What are they and do they effect cardiovascular health?
This review examines the cardiovascular health effects of micro- and nanoplastics, summarizing evidence that these particles have been detected in human tissues including arterial plaques and may promote endothelial dysfunction and inflammation. The authors call for further clinical and epidemiological research into cardiac risk.
Microplastics: A Modifiable Cardiac Risk Factor
This review examines the emerging evidence linking microplastic exposure to cardiovascular disease risk factors, including oxidative stress, inflammation, endothelial dysfunction, and thrombosis. The study highlights that micro- and nanoplastics have been identified in coronary artery plaque, suggesting that microplastic exposure may represent a modifiable but currently underrecognized cardiac risk factor.
Microplastics and Cardiovascular Disease: Should Clinicians Be Paying Attention?
This clinical review summarizes evidence for microplastics as a cardiovascular risk factor, noting that they have been detected in human cardiovascular tissues and that in vitro and animal studies link them to oxidative stress, endothelial dysfunction, and platelet disruption, while cautioning that human evidence remains associative.
Micro-nanoplastics and cardiovascular diseases: evidence and perspectives
Growing evidence suggests that micro- and nanoplastic particles may be a previously unrecognized risk factor for heart disease, as they have been detected in atherosclerotic plaques, heart tissue, and blood clots in humans. Lab studies show these particles can trigger oxidative stress, promote blood clotting, and cause inflammation in blood vessel cells, and their presence in artery plaques has been linked to higher rates of cardiovascular events.
Evidence, Mechanisms, and Clinical Implications of Microplastics and Nanoplastics As Emerging Cardiovascular Risk Factors: A Narrative Review
This review examines growing evidence that micro- and nanoplastics may contribute to cardiovascular health risks, with researchers having found these particles in human artery plaques and blood clots. Evidence indicates that the particles can enter the bloodstream, trigger inflammation, damage blood vessel walls, and potentially increase the risk of heart attacks and strokes. While the evidence is not yet conclusive, the study highlights an emerging area of concern that warrants further investigation into how everyday plastic exposure may affect heart and blood vessel health.